A business in context

MCK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-15 · 0000927653-26-000255

  2. 8-K · Current report

    Report date 2026-10-06 · 0000927653-26-000253 · Items 7.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-08 · 0000927653-26-000249

  4. 8-K · Current report

    Report date 2026-08-25 · 0000927653-26-000247 · Items 7.01,9.01

  5. 4 · Ownership change

    Report date 2026-08-07 · 0000927653-26-000240

  6. 4 · Ownership change

    Report date 2026-08-10 · 0000927653-26-000239

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000927653-26-000234

  8. 8-K · Current report

    Report date 2026-08-05 · 0000927653-26-000232 · Items 2.02,9.01

  9. 8-K · Current report

    Report date 2026-07-22 · 0000927653-26-000215 · Items 5.07

  10. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000209

  11. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000208

  12. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000207

  13. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000206

  14. 8-K · Current report

    Report date 2026-06-29 · 0000927653-26-000185 · Items 5.02,7.01,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-03-31 · 0000927653-26-000169

  16. 8-K · Current report

    Report date 2026-06-09 · 0000927653-26-000167 · Items 1.01,2.03,9.01

  17. 10-K · Annual report

    Report date 2026-03-31 · 0000927653-26-000069

  18. 8-K · Current report

    Report date 2026-05-07 · 0000927653-26-000066 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-04-28 · 0000927653-26-000053 · Items 1.01,1.02,2.03,9.01

  20. 8-K · Current report

    Report date 2026-04-01 · 0000927653-26-000045 · Items 1.01,2.03,9.01

  21. 8-K · Current report

    Report date 2026-03-06 · 0000927653-26-000038 · Items 7.01,9.01

  22. 8-K · Current report

    Report date 2026-03-03 · 0000927653-26-000035 · Items 5.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-12-31 · 0000927653-26-000017

  24. 8-K · Current report

    Report date 2026-02-04 · 0000927653-26-000015 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000927653-25-000140

  26. 8-K · Current report

    Report date 2025-11-05 · 0000927653-25-000138 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-09-23 · 0000927653-25-000125 · Items 7.01,9.01

  28. 8-K · Current report

    Report date 2025-09-18 · 0000927653-25-000121 · Items 2.02,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000927653-25-000107

  30. 8-K · Current report

    Report date 2025-08-06 · 0000927653-25-000105 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-07-30 · 0000927653-25-000096 · Items 5.07

  32. DEF 14A · Proxy statement

    Report date 2025-03-31 · 0000927653-25-000061

  33. 8-K · Current report

    Report date 2025-06-09 · 0000927653-25-000045 · Items 7.01

  34. 8-K · Current report

    Report date 2025-05-20 · 0001628280-25-028495 · Items 2.03,8.01,9.01

  35. 10-K · Annual report

    Report date 2025-03-31 · 0000927653-25-000036

  36. 8-K · Current report

    Report date 2025-05-08 · 0000927653-25-000034 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000927653-25-000014

  38. 8-K/A · Current report

    Report date 2025-02-05 · 0000927653-25-000012 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-02-05 · 0000927653-25-000010 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000927653-24-000125

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 11 transaction rows11AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

14 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-10
Rutledge Napoleon B JR
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock111.0891.45
2026-08-10
2026-08-11
Lerman Bradley ES · Sale
Disposed
Common Stock301.0892.33
2026-08-07
2026-08-11
Srinivasan Ramesh (NMN)A · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
368.00.0
2026-07-22
2026-07-23
Hinton James H.A · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Doughtie Lynne MA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Wilson-Thompson KathleenA · Grant / award
Acquired
Common Stock277.0814.04
2026-07-22
2026-07-23
Dunbar Webster RoyA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Caruso Dominic JA · Grant / award
Acquired
Common Stock277.0814.04
2026-07-22
2026-07-23
Gerberding Julie L.A · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Lerman Bradley EA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Martinez MariaA · Grant / award
Acquired
Common Stock277.0814.04
2026-07-22
2026-07-23
OZAN KEVIN MA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-22
2026-07-23
Dunsire DeborahA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
277.00.0
2026-07-07
2026-07-08
TYLER BRIAN S.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8463.0793.56

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000927653MCKESSON CORP
McKesson Europe AGHealth MartRemedy'sRxGuardianI.D.A.US Oncology NetworkNorsk Medisinaldepot

Showing 7 of 7 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300WZWOM80UCFSF54
GLEIF legal name
MCKESSON CORPORATION
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-01-30T08:04:06Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • McKesson Corporation · alias · wikidata
  • McKesson Health Solutions · alias · wikidata
  • McKesson · alias · wikidata
  • McKesson Europe AG · subsidiary · wikidata
  • Celesio AG · subsidiary · wikidata
  • Health Mart · subsidiary · wikidata
  • Health Mart Pharmacy · subsidiary · wikidata
  • Remedy'sRx · subsidiary · wikidata
  • Guardian · subsidiary · wikidata
  • Guardian Pharmacy · subsidiary · wikidata
  • Guardian Drugs · subsidiary · wikidata
  • I.D.A. · subsidiary · wikidata
  • IDA Pharmacy · subsidiary · wikidata
  • IDA · subsidiary · wikidata
  • US Oncology Network · subsidiary · wikidata
  • Norsk Medisinaldepot · subsidiary · wikidata
  • MCKESSON HBOC INC · former SEC name · 1999-09-10 to 2001-08-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-03-31$359.05B$383.09B
2024-03-31$308.95B$338.93B
2023-03-31$276.71B$314.17B
2022-03-31$263.97B$322.03B
2021-03-31$238.23B$308.69B
2020-03-31$231.05B$302.93B
2019-03-31$214.32B$286.41B
2018-03-31$208.36B$284.86B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗